Sorry, you need to enable JavaScript to visit this website.

Crisaborole Ointment 2% Skin Biomarker Biopsy Study in Atopic Dermatitis

A Phase 2a, Randomized, Double-Blind, Vehicle-Controlled Study, to Characterize the Mechanism of Action of
Crisaborole Ointment 2%, by Evaluation of Efficacy and Changes in Skin Biomarkers, in Adult Subjects With Mild to Moderate Atopic Dermatitis, With a 4 Week Open-Label Extension

Category & Conditions: Skin Diseases and Conditions
Medicine: EUCRISA™(CRISABOROLE) Identifier (NCT): NCT03233529
Protocol ID: C3291001
Open Plain Language Summary Result: Click here